Review




Structured Review

National Centre for Cell Science human cervical cancer cell line siha
Human Cervical Cancer Cell Line Siha, supplied by National Centre for Cell Science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human cervical cancer cell line siha/product/National Centre for Cell Science
Average 90 stars, based on 1 article reviews
human cervical cancer cell line siha - by Bioz Stars, 2026-02
90/100 stars

Images



Similar Products

99
ATCC siha human cervical cancer cell lines
Siha Human Cervical Cancer Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/siha human cervical cancer cell lines/product/ATCC
Average 99 stars, based on 1 article reviews
siha human cervical cancer cell lines - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

99
ATCC human cervical cancer cell line siha
Human Cervical Cancer Cell Line Siha, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human cervical cancer cell line siha/product/ATCC
Average 99 stars, based on 1 article reviews
human cervical cancer cell line siha - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

99
ATCC human cervical cancer siha cell line
CircPOLD1 promotes the proliferation through directly binding to YBX1 <t>in</t> <t>cervical</t> cancer cells. A Schematic representation of the sites of the siRNAs specific to the back-splice junction of circPOLD1. B The circPOLD1 and POLD1 mRNA expression measured by qRT-PCR analysis in <t>SiHa</t> and CaSki cells after transfected with two siRNAs. Data were the means ± SEM of three independent experiments (*P < 0.05, **P < 0.01, ***P < 0.001, Student’s t-test). C The proliferation measured by CCK-8 assay in SiHa and CaSki cells transfected with circPOLD1 siRNAs, oligo control (oligo) and without treated (wildtype). Data were the means ± SEM of three experiments (*P < 0.05, **P < 0.01, ***P < 0.001, Student’s t-test). D Representative image (left) and quantification (right panel) of colony formation assays in SiHa and CaSki cells transfected with circPOLD1 siRNAs or oligo control. Data were the means ± SEM of three experiments (*P < 0.05, **P < 0.01, Student’s t-test). E Apoptotic rates measured by flow cytometry in SiHa and CaSki cells transfected with circPOLD1 siRNAs or oligo control. Data were the means ± SEM of five experiments (*P < 0.05, **P < 0.01, Student’s t-test). F The circPOLD1 expression measured by qRT-PCR in SiHa cells after stably transfected with circPOLD1 shRNA(sh-circPOLD1) or oligo shRNA(oligo). G SiHa cells with stably transfected sh-circPOLD1 or oligo were subcutaneously injected into 6 BALB/c nude mice (4–6 weeks old, female), respectively, to establish the xenograft models. Top panel: The growths of xenografts were compared between sh-circPOLD1 and oligo group (*P < 0.05, **P < 0.01, ***P < 0.001, Student’s t-test). Tumor volumes were measured per week. Bottom panel: The photo showed the sizes of tumors when mice were sacrificed at week 8. H YBX1, the circPOLD1 binding protein predicted by online web server RBPmap. I , J Probes targeting back-splice junction of circPOLD1 and control oligo were transcribed in vitro, biotinylated, captured by streptavidin magnetic beads, and incubated with CaSki whole-cell lysates for RNA pull-down assays. The expression level of RNA measured by qRT-PCR in the eluate (left). CircPLD1 specific bands were assessed by Western blotting (right). Data were the means ± SEM of three experiments (*P < 0.05, Student’s t-test). K RIP assays were performed using antibodies against YBX1 in CaSki cells. The quantity of circPOLD1 was evaluated by qRT-PCR. Data were the means ± SEM of three experiments (*P < 0.05, Student’s t-test). L The expression level of YBX1 protein in SiHa cells after treated with two YBX1 siRNAs. M The proliferation by CCK-8 assay in SiHa and CaSki cells transfected with oligo control or YBX1 siRNAs. Data were the means ± SEM of three experiments (*P < 0.05, **P < 0.01, One-way ANOVA). N Representative images (left) and quantification (right) of colony formation assays in SiHa and CaSki cells transfected with YBX1 siRNAs or control. Data were the means ± SEM of three experiments (*P < 0.05, **P < 0.01, One-way ANOVA). O Co-transfection with circPOLD1 siRNA (si-circPOLD1) and YBX1 plasmid in CaSki cells was established. Down-regulated circPOLD1 expression and up-regulated YBX1 expression were evaluated by qRT-PCR. P Relative mRNA expressions of three downstream target genes of YBX1 (CDC25A, CIAPIN1 and XIAP) were measured by qRT-PCR in CaSki cells treated with control vector, si-circPOLD1, and si-circPOLD1 plus YBX1, respectively. Q The proliferation measured by CCK8 assay in CaSki cells treated with control vector, si-circPOLD1, and si-circPOLD1 plus YBX1, respectively. R Representative images of colony formation assays in CaSki cells treated with control vector, si-circPOLD1 and si-circPOLD1 plus YBX1, respectively. Data were the means ± SEM of three experiments (*P < 0.05, **P < 0.01, One-way ANOVA)
Human Cervical Cancer Siha Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human cervical cancer siha cell line/product/ATCC
Average 99 stars, based on 1 article reviews
human cervical cancer siha cell line - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

99
ATCC clinical specimens human cervical cancer cc cell lines
CircPOLD1 promotes the proliferation through directly binding to YBX1 <t>in</t> <t>cervical</t> cancer cells. A Schematic representation of the sites of the siRNAs specific to the back-splice junction of circPOLD1. B The circPOLD1 and POLD1 mRNA expression measured by qRT-PCR analysis in <t>SiHa</t> and CaSki cells after transfected with two siRNAs. Data were the means ± SEM of three independent experiments (*P < 0.05, **P < 0.01, ***P < 0.001, Student’s t-test). C The proliferation measured by CCK-8 assay in SiHa and CaSki cells transfected with circPOLD1 siRNAs, oligo control (oligo) and without treated (wildtype). Data were the means ± SEM of three experiments (*P < 0.05, **P < 0.01, ***P < 0.001, Student’s t-test). D Representative image (left) and quantification (right panel) of colony formation assays in SiHa and CaSki cells transfected with circPOLD1 siRNAs or oligo control. Data were the means ± SEM of three experiments (*P < 0.05, **P < 0.01, Student’s t-test). E Apoptotic rates measured by flow cytometry in SiHa and CaSki cells transfected with circPOLD1 siRNAs or oligo control. Data were the means ± SEM of five experiments (*P < 0.05, **P < 0.01, Student’s t-test). F The circPOLD1 expression measured by qRT-PCR in SiHa cells after stably transfected with circPOLD1 shRNA(sh-circPOLD1) or oligo shRNA(oligo). G SiHa cells with stably transfected sh-circPOLD1 or oligo were subcutaneously injected into 6 BALB/c nude mice (4–6 weeks old, female), respectively, to establish the xenograft models. Top panel: The growths of xenografts were compared between sh-circPOLD1 and oligo group (*P < 0.05, **P < 0.01, ***P < 0.001, Student’s t-test). Tumor volumes were measured per week. Bottom panel: The photo showed the sizes of tumors when mice were sacrificed at week 8. H YBX1, the circPOLD1 binding protein predicted by online web server RBPmap. I , J Probes targeting back-splice junction of circPOLD1 and control oligo were transcribed in vitro, biotinylated, captured by streptavidin magnetic beads, and incubated with CaSki whole-cell lysates for RNA pull-down assays. The expression level of RNA measured by qRT-PCR in the eluate (left). CircPLD1 specific bands were assessed by Western blotting (right). Data were the means ± SEM of three experiments (*P < 0.05, Student’s t-test). K RIP assays were performed using antibodies against YBX1 in CaSki cells. The quantity of circPOLD1 was evaluated by qRT-PCR. Data were the means ± SEM of three experiments (*P < 0.05, Student’s t-test). L The expression level of YBX1 protein in SiHa cells after treated with two YBX1 siRNAs. M The proliferation by CCK-8 assay in SiHa and CaSki cells transfected with oligo control or YBX1 siRNAs. Data were the means ± SEM of three experiments (*P < 0.05, **P < 0.01, One-way ANOVA). N Representative images (left) and quantification (right) of colony formation assays in SiHa and CaSki cells transfected with YBX1 siRNAs or control. Data were the means ± SEM of three experiments (*P < 0.05, **P < 0.01, One-way ANOVA). O Co-transfection with circPOLD1 siRNA (si-circPOLD1) and YBX1 plasmid in CaSki cells was established. Down-regulated circPOLD1 expression and up-regulated YBX1 expression were evaluated by qRT-PCR. P Relative mRNA expressions of three downstream target genes of YBX1 (CDC25A, CIAPIN1 and XIAP) were measured by qRT-PCR in CaSki cells treated with control vector, si-circPOLD1, and si-circPOLD1 plus YBX1, respectively. Q The proliferation measured by CCK8 assay in CaSki cells treated with control vector, si-circPOLD1, and si-circPOLD1 plus YBX1, respectively. R Representative images of colony formation assays in CaSki cells treated with control vector, si-circPOLD1 and si-circPOLD1 plus YBX1, respectively. Data were the means ± SEM of three experiments (*P < 0.05, **P < 0.01, One-way ANOVA)
Clinical Specimens Human Cervical Cancer Cc Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/clinical specimens human cervical cancer cc cell lines/product/ATCC
Average 99 stars, based on 1 article reviews
clinical specimens human cervical cancer cc cell lines - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

99
ATCC human cervical cancer cc cell lines
CircPOLD1 promotes the proliferation through directly binding to YBX1 <t>in</t> <t>cervical</t> cancer cells. A Schematic representation of the sites of the siRNAs specific to the back-splice junction of circPOLD1. B The circPOLD1 and POLD1 mRNA expression measured by qRT-PCR analysis in <t>SiHa</t> and CaSki cells after transfected with two siRNAs. Data were the means ± SEM of three independent experiments (*P < 0.05, **P < 0.01, ***P < 0.001, Student’s t-test). C The proliferation measured by CCK-8 assay in SiHa and CaSki cells transfected with circPOLD1 siRNAs, oligo control (oligo) and without treated (wildtype). Data were the means ± SEM of three experiments (*P < 0.05, **P < 0.01, ***P < 0.001, Student’s t-test). D Representative image (left) and quantification (right panel) of colony formation assays in SiHa and CaSki cells transfected with circPOLD1 siRNAs or oligo control. Data were the means ± SEM of three experiments (*P < 0.05, **P < 0.01, Student’s t-test). E Apoptotic rates measured by flow cytometry in SiHa and CaSki cells transfected with circPOLD1 siRNAs or oligo control. Data were the means ± SEM of five experiments (*P < 0.05, **P < 0.01, Student’s t-test). F The circPOLD1 expression measured by qRT-PCR in SiHa cells after stably transfected with circPOLD1 shRNA(sh-circPOLD1) or oligo shRNA(oligo). G SiHa cells with stably transfected sh-circPOLD1 or oligo were subcutaneously injected into 6 BALB/c nude mice (4–6 weeks old, female), respectively, to establish the xenograft models. Top panel: The growths of xenografts were compared between sh-circPOLD1 and oligo group (*P < 0.05, **P < 0.01, ***P < 0.001, Student’s t-test). Tumor volumes were measured per week. Bottom panel: The photo showed the sizes of tumors when mice were sacrificed at week 8. H YBX1, the circPOLD1 binding protein predicted by online web server RBPmap. I , J Probes targeting back-splice junction of circPOLD1 and control oligo were transcribed in vitro, biotinylated, captured by streptavidin magnetic beads, and incubated with CaSki whole-cell lysates for RNA pull-down assays. The expression level of RNA measured by qRT-PCR in the eluate (left). CircPLD1 specific bands were assessed by Western blotting (right). Data were the means ± SEM of three experiments (*P < 0.05, Student’s t-test). K RIP assays were performed using antibodies against YBX1 in CaSki cells. The quantity of circPOLD1 was evaluated by qRT-PCR. Data were the means ± SEM of three experiments (*P < 0.05, Student’s t-test). L The expression level of YBX1 protein in SiHa cells after treated with two YBX1 siRNAs. M The proliferation by CCK-8 assay in SiHa and CaSki cells transfected with oligo control or YBX1 siRNAs. Data were the means ± SEM of three experiments (*P < 0.05, **P < 0.01, One-way ANOVA). N Representative images (left) and quantification (right) of colony formation assays in SiHa and CaSki cells transfected with YBX1 siRNAs or control. Data were the means ± SEM of three experiments (*P < 0.05, **P < 0.01, One-way ANOVA). O Co-transfection with circPOLD1 siRNA (si-circPOLD1) and YBX1 plasmid in CaSki cells was established. Down-regulated circPOLD1 expression and up-regulated YBX1 expression were evaluated by qRT-PCR. P Relative mRNA expressions of three downstream target genes of YBX1 (CDC25A, CIAPIN1 and XIAP) were measured by qRT-PCR in CaSki cells treated with control vector, si-circPOLD1, and si-circPOLD1 plus YBX1, respectively. Q The proliferation measured by CCK8 assay in CaSki cells treated with control vector, si-circPOLD1, and si-circPOLD1 plus YBX1, respectively. R Representative images of colony formation assays in CaSki cells treated with control vector, si-circPOLD1 and si-circPOLD1 plus YBX1, respectively. Data were the means ± SEM of three experiments (*P < 0.05, **P < 0.01, One-way ANOVA)
Human Cervical Cancer Cc Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human cervical cancer cc cell lines/product/ATCC
Average 99 stars, based on 1 article reviews
human cervical cancer cc cell lines - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

99
ATCC human cervical cancer cell lines
CircPOLD1 promotes the proliferation through directly binding to YBX1 <t>in</t> <t>cervical</t> cancer cells. A Schematic representation of the sites of the siRNAs specific to the back-splice junction of circPOLD1. B The circPOLD1 and POLD1 mRNA expression measured by qRT-PCR analysis in <t>SiHa</t> and CaSki cells after transfected with two siRNAs. Data were the means ± SEM of three independent experiments (*P < 0.05, **P < 0.01, ***P < 0.001, Student’s t-test). C The proliferation measured by CCK-8 assay in SiHa and CaSki cells transfected with circPOLD1 siRNAs, oligo control (oligo) and without treated (wildtype). Data were the means ± SEM of three experiments (*P < 0.05, **P < 0.01, ***P < 0.001, Student’s t-test). D Representative image (left) and quantification (right panel) of colony formation assays in SiHa and CaSki cells transfected with circPOLD1 siRNAs or oligo control. Data were the means ± SEM of three experiments (*P < 0.05, **P < 0.01, Student’s t-test). E Apoptotic rates measured by flow cytometry in SiHa and CaSki cells transfected with circPOLD1 siRNAs or oligo control. Data were the means ± SEM of five experiments (*P < 0.05, **P < 0.01, Student’s t-test). F The circPOLD1 expression measured by qRT-PCR in SiHa cells after stably transfected with circPOLD1 shRNA(sh-circPOLD1) or oligo shRNA(oligo). G SiHa cells with stably transfected sh-circPOLD1 or oligo were subcutaneously injected into 6 BALB/c nude mice (4–6 weeks old, female), respectively, to establish the xenograft models. Top panel: The growths of xenografts were compared between sh-circPOLD1 and oligo group (*P < 0.05, **P < 0.01, ***P < 0.001, Student’s t-test). Tumor volumes were measured per week. Bottom panel: The photo showed the sizes of tumors when mice were sacrificed at week 8. H YBX1, the circPOLD1 binding protein predicted by online web server RBPmap. I , J Probes targeting back-splice junction of circPOLD1 and control oligo were transcribed in vitro, biotinylated, captured by streptavidin magnetic beads, and incubated with CaSki whole-cell lysates for RNA pull-down assays. The expression level of RNA measured by qRT-PCR in the eluate (left). CircPLD1 specific bands were assessed by Western blotting (right). Data were the means ± SEM of three experiments (*P < 0.05, Student’s t-test). K RIP assays were performed using antibodies against YBX1 in CaSki cells. The quantity of circPOLD1 was evaluated by qRT-PCR. Data were the means ± SEM of three experiments (*P < 0.05, Student’s t-test). L The expression level of YBX1 protein in SiHa cells after treated with two YBX1 siRNAs. M The proliferation by CCK-8 assay in SiHa and CaSki cells transfected with oligo control or YBX1 siRNAs. Data were the means ± SEM of three experiments (*P < 0.05, **P < 0.01, One-way ANOVA). N Representative images (left) and quantification (right) of colony formation assays in SiHa and CaSki cells transfected with YBX1 siRNAs or control. Data were the means ± SEM of three experiments (*P < 0.05, **P < 0.01, One-way ANOVA). O Co-transfection with circPOLD1 siRNA (si-circPOLD1) and YBX1 plasmid in CaSki cells was established. Down-regulated circPOLD1 expression and up-regulated YBX1 expression were evaluated by qRT-PCR. P Relative mRNA expressions of three downstream target genes of YBX1 (CDC25A, CIAPIN1 and XIAP) were measured by qRT-PCR in CaSki cells treated with control vector, si-circPOLD1, and si-circPOLD1 plus YBX1, respectively. Q The proliferation measured by CCK8 assay in CaSki cells treated with control vector, si-circPOLD1, and si-circPOLD1 plus YBX1, respectively. R Representative images of colony formation assays in CaSki cells treated with control vector, si-circPOLD1 and si-circPOLD1 plus YBX1, respectively. Data were the means ± SEM of three experiments (*P < 0.05, **P < 0.01, One-way ANOVA)
Human Cervical Cancer Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human cervical cancer cell lines/product/ATCC
Average 99 stars, based on 1 article reviews
human cervical cancer cell lines - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

90
National Centre for Cell Science human cervical cancer cell line siha
CircPOLD1 promotes the proliferation through directly binding to YBX1 <t>in</t> <t>cervical</t> cancer cells. A Schematic representation of the sites of the siRNAs specific to the back-splice junction of circPOLD1. B The circPOLD1 and POLD1 mRNA expression measured by qRT-PCR analysis in <t>SiHa</t> and CaSki cells after transfected with two siRNAs. Data were the means ± SEM of three independent experiments (*P < 0.05, **P < 0.01, ***P < 0.001, Student’s t-test). C The proliferation measured by CCK-8 assay in SiHa and CaSki cells transfected with circPOLD1 siRNAs, oligo control (oligo) and without treated (wildtype). Data were the means ± SEM of three experiments (*P < 0.05, **P < 0.01, ***P < 0.001, Student’s t-test). D Representative image (left) and quantification (right panel) of colony formation assays in SiHa and CaSki cells transfected with circPOLD1 siRNAs or oligo control. Data were the means ± SEM of three experiments (*P < 0.05, **P < 0.01, Student’s t-test). E Apoptotic rates measured by flow cytometry in SiHa and CaSki cells transfected with circPOLD1 siRNAs or oligo control. Data were the means ± SEM of five experiments (*P < 0.05, **P < 0.01, Student’s t-test). F The circPOLD1 expression measured by qRT-PCR in SiHa cells after stably transfected with circPOLD1 shRNA(sh-circPOLD1) or oligo shRNA(oligo). G SiHa cells with stably transfected sh-circPOLD1 or oligo were subcutaneously injected into 6 BALB/c nude mice (4–6 weeks old, female), respectively, to establish the xenograft models. Top panel: The growths of xenografts were compared between sh-circPOLD1 and oligo group (*P < 0.05, **P < 0.01, ***P < 0.001, Student’s t-test). Tumor volumes were measured per week. Bottom panel: The photo showed the sizes of tumors when mice were sacrificed at week 8. H YBX1, the circPOLD1 binding protein predicted by online web server RBPmap. I , J Probes targeting back-splice junction of circPOLD1 and control oligo were transcribed in vitro, biotinylated, captured by streptavidin magnetic beads, and incubated with CaSki whole-cell lysates for RNA pull-down assays. The expression level of RNA measured by qRT-PCR in the eluate (left). CircPLD1 specific bands were assessed by Western blotting (right). Data were the means ± SEM of three experiments (*P < 0.05, Student’s t-test). K RIP assays were performed using antibodies against YBX1 in CaSki cells. The quantity of circPOLD1 was evaluated by qRT-PCR. Data were the means ± SEM of three experiments (*P < 0.05, Student’s t-test). L The expression level of YBX1 protein in SiHa cells after treated with two YBX1 siRNAs. M The proliferation by CCK-8 assay in SiHa and CaSki cells transfected with oligo control or YBX1 siRNAs. Data were the means ± SEM of three experiments (*P < 0.05, **P < 0.01, One-way ANOVA). N Representative images (left) and quantification (right) of colony formation assays in SiHa and CaSki cells transfected with YBX1 siRNAs or control. Data were the means ± SEM of three experiments (*P < 0.05, **P < 0.01, One-way ANOVA). O Co-transfection with circPOLD1 siRNA (si-circPOLD1) and YBX1 plasmid in CaSki cells was established. Down-regulated circPOLD1 expression and up-regulated YBX1 expression were evaluated by qRT-PCR. P Relative mRNA expressions of three downstream target genes of YBX1 (CDC25A, CIAPIN1 and XIAP) were measured by qRT-PCR in CaSki cells treated with control vector, si-circPOLD1, and si-circPOLD1 plus YBX1, respectively. Q The proliferation measured by CCK8 assay in CaSki cells treated with control vector, si-circPOLD1, and si-circPOLD1 plus YBX1, respectively. R Representative images of colony formation assays in CaSki cells treated with control vector, si-circPOLD1 and si-circPOLD1 plus YBX1, respectively. Data were the means ± SEM of three experiments (*P < 0.05, **P < 0.01, One-way ANOVA)
Human Cervical Cancer Cell Line Siha, supplied by National Centre for Cell Science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human cervical cancer cell line siha/product/National Centre for Cell Science
Average 90 stars, based on 1 article reviews
human cervical cancer cell line siha - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


CircPOLD1 promotes the proliferation through directly binding to YBX1 in cervical cancer cells. A Schematic representation of the sites of the siRNAs specific to the back-splice junction of circPOLD1. B The circPOLD1 and POLD1 mRNA expression measured by qRT-PCR analysis in SiHa and CaSki cells after transfected with two siRNAs. Data were the means ± SEM of three independent experiments (*P < 0.05, **P < 0.01, ***P < 0.001, Student’s t-test). C The proliferation measured by CCK-8 assay in SiHa and CaSki cells transfected with circPOLD1 siRNAs, oligo control (oligo) and without treated (wildtype). Data were the means ± SEM of three experiments (*P < 0.05, **P < 0.01, ***P < 0.001, Student’s t-test). D Representative image (left) and quantification (right panel) of colony formation assays in SiHa and CaSki cells transfected with circPOLD1 siRNAs or oligo control. Data were the means ± SEM of three experiments (*P < 0.05, **P < 0.01, Student’s t-test). E Apoptotic rates measured by flow cytometry in SiHa and CaSki cells transfected with circPOLD1 siRNAs or oligo control. Data were the means ± SEM of five experiments (*P < 0.05, **P < 0.01, Student’s t-test). F The circPOLD1 expression measured by qRT-PCR in SiHa cells after stably transfected with circPOLD1 shRNA(sh-circPOLD1) or oligo shRNA(oligo). G SiHa cells with stably transfected sh-circPOLD1 or oligo were subcutaneously injected into 6 BALB/c nude mice (4–6 weeks old, female), respectively, to establish the xenograft models. Top panel: The growths of xenografts were compared between sh-circPOLD1 and oligo group (*P < 0.05, **P < 0.01, ***P < 0.001, Student’s t-test). Tumor volumes were measured per week. Bottom panel: The photo showed the sizes of tumors when mice were sacrificed at week 8. H YBX1, the circPOLD1 binding protein predicted by online web server RBPmap. I , J Probes targeting back-splice junction of circPOLD1 and control oligo were transcribed in vitro, biotinylated, captured by streptavidin magnetic beads, and incubated with CaSki whole-cell lysates for RNA pull-down assays. The expression level of RNA measured by qRT-PCR in the eluate (left). CircPLD1 specific bands were assessed by Western blotting (right). Data were the means ± SEM of three experiments (*P < 0.05, Student’s t-test). K RIP assays were performed using antibodies against YBX1 in CaSki cells. The quantity of circPOLD1 was evaluated by qRT-PCR. Data were the means ± SEM of three experiments (*P < 0.05, Student’s t-test). L The expression level of YBX1 protein in SiHa cells after treated with two YBX1 siRNAs. M The proliferation by CCK-8 assay in SiHa and CaSki cells transfected with oligo control or YBX1 siRNAs. Data were the means ± SEM of three experiments (*P < 0.05, **P < 0.01, One-way ANOVA). N Representative images (left) and quantification (right) of colony formation assays in SiHa and CaSki cells transfected with YBX1 siRNAs or control. Data were the means ± SEM of three experiments (*P < 0.05, **P < 0.01, One-way ANOVA). O Co-transfection with circPOLD1 siRNA (si-circPOLD1) and YBX1 plasmid in CaSki cells was established. Down-regulated circPOLD1 expression and up-regulated YBX1 expression were evaluated by qRT-PCR. P Relative mRNA expressions of three downstream target genes of YBX1 (CDC25A, CIAPIN1 and XIAP) were measured by qRT-PCR in CaSki cells treated with control vector, si-circPOLD1, and si-circPOLD1 plus YBX1, respectively. Q The proliferation measured by CCK8 assay in CaSki cells treated with control vector, si-circPOLD1, and si-circPOLD1 plus YBX1, respectively. R Representative images of colony formation assays in CaSki cells treated with control vector, si-circPOLD1 and si-circPOLD1 plus YBX1, respectively. Data were the means ± SEM of three experiments (*P < 0.05, **P < 0.01, One-way ANOVA)

Journal: Journal of Translational Medicine

Article Title: The biomarker potential of circPOLD1 and its binding protein YBX1 in cervical carcinogenesis

doi: 10.1186/s12967-025-06494-3

Figure Lengend Snippet: CircPOLD1 promotes the proliferation through directly binding to YBX1 in cervical cancer cells. A Schematic representation of the sites of the siRNAs specific to the back-splice junction of circPOLD1. B The circPOLD1 and POLD1 mRNA expression measured by qRT-PCR analysis in SiHa and CaSki cells after transfected with two siRNAs. Data were the means ± SEM of three independent experiments (*P < 0.05, **P < 0.01, ***P < 0.001, Student’s t-test). C The proliferation measured by CCK-8 assay in SiHa and CaSki cells transfected with circPOLD1 siRNAs, oligo control (oligo) and without treated (wildtype). Data were the means ± SEM of three experiments (*P < 0.05, **P < 0.01, ***P < 0.001, Student’s t-test). D Representative image (left) and quantification (right panel) of colony formation assays in SiHa and CaSki cells transfected with circPOLD1 siRNAs or oligo control. Data were the means ± SEM of three experiments (*P < 0.05, **P < 0.01, Student’s t-test). E Apoptotic rates measured by flow cytometry in SiHa and CaSki cells transfected with circPOLD1 siRNAs or oligo control. Data were the means ± SEM of five experiments (*P < 0.05, **P < 0.01, Student’s t-test). F The circPOLD1 expression measured by qRT-PCR in SiHa cells after stably transfected with circPOLD1 shRNA(sh-circPOLD1) or oligo shRNA(oligo). G SiHa cells with stably transfected sh-circPOLD1 or oligo were subcutaneously injected into 6 BALB/c nude mice (4–6 weeks old, female), respectively, to establish the xenograft models. Top panel: The growths of xenografts were compared between sh-circPOLD1 and oligo group (*P < 0.05, **P < 0.01, ***P < 0.001, Student’s t-test). Tumor volumes were measured per week. Bottom panel: The photo showed the sizes of tumors when mice were sacrificed at week 8. H YBX1, the circPOLD1 binding protein predicted by online web server RBPmap. I , J Probes targeting back-splice junction of circPOLD1 and control oligo were transcribed in vitro, biotinylated, captured by streptavidin magnetic beads, and incubated with CaSki whole-cell lysates for RNA pull-down assays. The expression level of RNA measured by qRT-PCR in the eluate (left). CircPLD1 specific bands were assessed by Western blotting (right). Data were the means ± SEM of three experiments (*P < 0.05, Student’s t-test). K RIP assays were performed using antibodies against YBX1 in CaSki cells. The quantity of circPOLD1 was evaluated by qRT-PCR. Data were the means ± SEM of three experiments (*P < 0.05, Student’s t-test). L The expression level of YBX1 protein in SiHa cells after treated with two YBX1 siRNAs. M The proliferation by CCK-8 assay in SiHa and CaSki cells transfected with oligo control or YBX1 siRNAs. Data were the means ± SEM of three experiments (*P < 0.05, **P < 0.01, One-way ANOVA). N Representative images (left) and quantification (right) of colony formation assays in SiHa and CaSki cells transfected with YBX1 siRNAs or control. Data were the means ± SEM of three experiments (*P < 0.05, **P < 0.01, One-way ANOVA). O Co-transfection with circPOLD1 siRNA (si-circPOLD1) and YBX1 plasmid in CaSki cells was established. Down-regulated circPOLD1 expression and up-regulated YBX1 expression were evaluated by qRT-PCR. P Relative mRNA expressions of three downstream target genes of YBX1 (CDC25A, CIAPIN1 and XIAP) were measured by qRT-PCR in CaSki cells treated with control vector, si-circPOLD1, and si-circPOLD1 plus YBX1, respectively. Q The proliferation measured by CCK8 assay in CaSki cells treated with control vector, si-circPOLD1, and si-circPOLD1 plus YBX1, respectively. R Representative images of colony formation assays in CaSki cells treated with control vector, si-circPOLD1 and si-circPOLD1 plus YBX1, respectively. Data were the means ± SEM of three experiments (*P < 0.05, **P < 0.01, One-way ANOVA)

Article Snippet: Human cervical cancer SiHa cell line was obtained from the American Type Culture Collection (ATCC, USA).

Techniques: Binding Assay, Expressing, Quantitative RT-PCR, Transfection, CCK-8 Assay, Control, Flow Cytometry, Stable Transfection, shRNA, Injection, In Vitro, Magnetic Beads, Incubation, Western Blot, Cotransfection, Plasmid Preparation

CircPOLD1 regulates AKT/mTOR/HIF-1α and glycolysis signaling pathway through phosphorylating YBX1 in cervical cancer cells. A , B Left panel: The YBX1 and p-YBX1 protein expression in CaSki and SiHa cells transfected with circPOLD1 siRNAs or control through western blot. Right panel: The quantitative analysis of YBX1 and p-YBX1 protein expression by ImageJ (**P < 0.01, ***P < 0.001, One-way ANOVA). C Venn diagram showing the overlap differentially genes between si-YBX1 vs si-NC and si-circPOLD1 vs si-NC via RNA sequencing. D The cluster heatmap of overlap differentially expressed mRNAs in YBX1 and circPOLD1 knockdown or control cells. E The pathway enrichment analysis of overlapping differential genes between si-YBX1 vs si-NC and si-circPOLD1 vs si-NC via RNA sequencing. F Protein levels of YBX1, p-YBX1, LDHA, HK2, HIF-1α, mTOR, p-mTOR, AKT and p-AKT, were determined following transfection with two YBX1 siRNAs and si-NC in CaSki and SiHa cells. G The quantitative analysis of F by ImageJ (*P < 0.05, **P < 0.01, ***P < 0.001, One-way ANOVA). H Protein levels of LDHA, HK2, HIF-1α, mTOR, p-mTOR, AKT and p-AKT were determined following transfection with two circPOLD1 siRNAs and si-NC in CaSki and SiHa cells. I The quantitative analysis of H by ImageJ (**P < 0.01, ***P < 0.001, One-way ANOVA)

Journal: Journal of Translational Medicine

Article Title: The biomarker potential of circPOLD1 and its binding protein YBX1 in cervical carcinogenesis

doi: 10.1186/s12967-025-06494-3

Figure Lengend Snippet: CircPOLD1 regulates AKT/mTOR/HIF-1α and glycolysis signaling pathway through phosphorylating YBX1 in cervical cancer cells. A , B Left panel: The YBX1 and p-YBX1 protein expression in CaSki and SiHa cells transfected with circPOLD1 siRNAs or control through western blot. Right panel: The quantitative analysis of YBX1 and p-YBX1 protein expression by ImageJ (**P < 0.01, ***P < 0.001, One-way ANOVA). C Venn diagram showing the overlap differentially genes between si-YBX1 vs si-NC and si-circPOLD1 vs si-NC via RNA sequencing. D The cluster heatmap of overlap differentially expressed mRNAs in YBX1 and circPOLD1 knockdown or control cells. E The pathway enrichment analysis of overlapping differential genes between si-YBX1 vs si-NC and si-circPOLD1 vs si-NC via RNA sequencing. F Protein levels of YBX1, p-YBX1, LDHA, HK2, HIF-1α, mTOR, p-mTOR, AKT and p-AKT, were determined following transfection with two YBX1 siRNAs and si-NC in CaSki and SiHa cells. G The quantitative analysis of F by ImageJ (*P < 0.05, **P < 0.01, ***P < 0.001, One-way ANOVA). H Protein levels of LDHA, HK2, HIF-1α, mTOR, p-mTOR, AKT and p-AKT were determined following transfection with two circPOLD1 siRNAs and si-NC in CaSki and SiHa cells. I The quantitative analysis of H by ImageJ (**P < 0.01, ***P < 0.001, One-way ANOVA)

Article Snippet: Human cervical cancer SiHa cell line was obtained from the American Type Culture Collection (ATCC, USA).

Techniques: Expressing, Transfection, Control, Western Blot, RNA Sequencing, Knockdown